background
enterovirus
ev
parechovirus
pev
ubiquit
virus
caus
rang
ill
includ
acut
ill
children
age
year
object
describ
ev
pev
infect
among
children
us
studi
site
age
year
hospit
acut
infect
evand
pevneg
casepati
explor
viral
etiolog
method
particip
age
year
hospit
cerebrospin
fluid
csf
collect
routin
diagnost
test
demograph
clinic
data
abstract
medic
chart
residu
specimen
sent
cdc
confirmatori
test
type
result
elig
casepati
csf
specimen
avail
among
posit
ev
pev
casepati
n
age
month
evor
pevposit
casepati
none
posit
casepati
underli
condit
chief
complaint
n
fever
twelv
posit
casepati
admit
intens
care
icu
brief
hospit
stay
median
day
sequenc
reveal
varieti
ev
type
predomin
among
pevposit
casepati
conclus
rang
ev
pev
type
associ
acut
febril
ill
lead
hospit
children
age
month
approxim
half
ev
pev
casepati
admit
icu
length
hospit
stay
brief
ill
gener
selflimit
clinician
consid
ev
pev
infect
infant
present
febril
ill
among
pathogen
detect
cerebrospin
fluid
csf
specimen
ev
pev
common
particularli
young
infant
system
diseas
associ
ev
pev
result
seizur
multiorgan
involv
death
particularli
neonat
acquisit
ev
pev
common
among
children
age
year
account
report
known
age
nation
enteroviru
surveil
system
ness
histor
detect
tradit
reli
slow
labor
intens
cell
cultur
method
advanc
laboratori
techniqu
particularli
molecular
methodolog
allow
rapid
sensit
specif
identif
ev
pev
infect
clinic
public
health
purpos
ev
pev
type
frequent
report
ness
age
group
enteroviru
echovirus
coxsackievirus
http
doi
picornavirus
ubiquit
commonli
associ
inappar
mild
ill
human
howev
sever
ill
wellrecogn
particularli
young
children
role
picornavirus
acut
infect
children
eg
sepsi
mening
enceph
acut
paralysi
often
underrecogn
due
lack
appropri
specimen
earli
cours
ill
lack
test
certain
common
picornavirus
parechovirus
pev
hospit
enteroviru
ev
parechoviru
genera
within
famili
picornavirida
genet
biolog
distinct
share
mani
epidemiolog
clinic
characterist
morbid
mortal
associ
ev
pev
may
occur
age
gener
sever
infect
occur
younger
age
group
parechoviru
predomin
viru
type
vari
among
year
better
defin
role
picornavirus
acut
infect
infant
character
ev
pev
infect
previous
healthi
children
age
year
hospit
acut
ill
two
studi
site
addit
evand
pevneg
specimen
test
virus
broadli
reactiv
panvir
group
polymeras
chain
reaction
pcr
elig
studi
particip
includ
children
age
year
hospit
one
studi
site
lumbar
punctur
lp
perform
cours
treatment
acut
ill
csf
submit
laboratori
test
particip
site
includ
colorado
emerg
infect
program
eip
includ
children
hospit
colorado
chc
facil
pediatr
referr
hospit
colorado
surround
state
california
eip
includ
univers
california
san
francisco
ucsf
benioff
children
hospit
oakland
referr
facil
ucsf
medic
center
referr
facil
elig
particip
enrol
colorado
site
januari
decemb
california
site
june
decemb
enrol
particip
data
demograph
symptom
hospit
cours
abstract
medic
chart
follow
patient
discharg
data
enter
webbas
databas
deidentifi
avail
residu
csf
serum
specimen
collect
hospit
ship
cdc
laboratori
test
specimen
screen
use
panev
panpev
realtim
rtpcr
test
addit
csf
specimen
test
use
ev
pev
rtpcr
assay
follow
sanger
sequenc
amplicon
determin
type
sampl
neg
ev
pev
test
virus
use
panvir
famili
genu
pcr
assay
follow
virus
alphavirus
astrovirus
bornavirus
bunyavirus
coronavirus
flavirus
influenza
virus
paramyxovirus
rhabdovirus
adenovirus
anellovirus
herpesvirus
posit
band
expect
size
sanger
sequenc
pcr
primer
determin
viru
speci
data
analysi
perform
use
microsoft
excel
sa
fund
studi
provid
cdc
nation
center
immun
respiratori
diseas
cooper
agreement
two
eip
site
studi
protocol
review
human
subject
research
committe
particip
site
approv
research
chc
institut
review
board
approv
obtain
determin
public
health
practic
ucsf
hospit
irb
approv
requir
although
cdc
determin
studi
human
subject
research
cdc
irb
approv
requir
cdc
consid
engag
research
casepati
met
elig
criteria
fig
residu
csf
test
receiv
cdc
casepati
differ
test
age
p
underli
medic
condit
p
icu
admiss
p
casepati
residu
csf
serum
specimen
receiv
casepati
residu
csf
n
among
casepati
csf
specimen
test
posit
either
ev
n
pev
n
tabl
serum
specimen
test
neg
ev
pev
major
n
enrol
case
age
less
month
evand
pevposit
case
male
compris
n
enrol
case
includ
n
evposit
case
n
pevposit
case
evposit
case
admit
may
decemb
pevposit
case
admit
march
decemb
fig
none
evor
pevposit
casepati
underli
condit
evposit
casepati
deliv
preterm
week
gestat
age
chief
complaint
report
fever
evor
pevposit
case
rash
evposit
case
cheek
swell
pevposit
case
six
evposit
case
admit
intens
care
unit
icu
rang
icu
stay
day
pevposit
case
rang
icu
stay
day
length
hospit
stay
rang
day
median
day
evposit
case
day
median
day
pevposit
case
none
evor
pevposit
case
requir
mechan
ventil
discharg
home
improv
condit
evor
pevposit
casepati
receiv
antimicrobi
empir
hospit
blood
cultur
csf
cultur
csf
gram
stain
reveal
bacteri
etiolog
urin
cultur
one
evposit
casepati
posit
escherichia
coli
acyclovir
empir
administ
evposit
casepati
pevposit
casepati
among
casepati
nontraumat
lp
defin
csf
red
blood
cell
count
median
csf
white
blood
cell
count
rang
neonat
age
day
n
rang
infant
age
day
n
tabl
type
success
perform
evposit
case
reveal
divers
type
tabl
follow
type
identifi
uniqu
case
coxsackievirus
cv
echovirus
identifi
separ
case
comparison
pevposit
case
domin
singl
type
identifi
case
identifi
case
specimen
neg
result
ev
pev
test
virus
human
herpesviru
detect
csf
specimen
one
old
male
present
fever
lower
limb
cellul
myositi
admit
neonat
icu
discharg
day
serum
specimen
casepati
posit
use
pananelloviru
pcr
assay
specimen
neg
virus
test
among
children
age
year
hospit
acut
ill
studi
site
ev
pev
detect
csf
half
posit
casepati
initi
admit
icu
hospit
length
stay
brief
ill
gener
selflimit
picornavirus
detect
csf
repres
rang
common
circul
type
children
present
acut
febril
ill
previou
retrospect
studi
use
compar
popul
ev
posit
rang
pevposit
rang
possibl
reflect
differ
studi
method
time
enrol
rel
season
annual
variat
picornaviru
circul
prospect
studi
span
year
found
ev
pev
howev
ev
type
success
pevtyp
avail
specimen
earlier
cours
ill
inclus
multipl
year
may
contribut
higher
proport
ev
pev
detect
comparison
studi
note
previou
studi
ev
pev
detect
concentr
among
children
age
month
wide
divers
ev
type
predomin
among
pevposit
casepati
characterist
sever
picornaviru
infect
also
reflect
commun
circul
demonstr
report
ness
ev
tabl
demograph
clinic
characterist
enrol
casepati
ie
age
less
year
hospit
studi
site
receiv
lumbar
punctur
residu
cerebrospin
fluid
specimen
avail
test
cdc
highest
temperatur
record
hospit
c
acyclovir
report
antivir
agent
pev
type
detect
studi
repres
among
ness
report
among
top
frequent
report
type
year
children
age
month
constitut
enrol
casepati
young
infant
present
fever
typic
lp
perform
admit
empir
antibiot
treatment
undergo
diagnost
evalu
bacteri
sepsi
case
place
acyclovir
suspicion
dissemin
herp
simplex
viru
hsv
infect
children
age
month
less
like
lp
perform
may
decreas
likelihood
ev
pev
detect
csf
group
studi
subject
limit
first
although
enrol
span
one
year
one
hospit
six
month
two
other
circul
ev
type
known
vari
year
year
multipl
year
enrol
would
comprehens
describ
ev
pev
circul
among
acut
ill
infant
second
substanti
proport
elig
casepati
residu
csf
specimen
avail
test
cdc
abl
includ
studi
although
significantli
differ
residu
csf
key
paramet
third
specimen
initi
collect
clinic
diagnost
test
residu
specimen
store
later
transport
character
cdc
repeat
freezethaw
cycl
might
advers
affect
specimen
qualiti
potenti
contribut
fals
neg
result
picornavirus
associ
rang
symptom
sever
children
clinic
manifest
associ
specif
ev
pev
type
remain
poorli
character
owe
part
chang
laboratori
test
practic
decreas
clinic
request
viral
type
qualit
test
ev
common
among
clinic
laboratori
test
detect
pev
clinic
laboratori
perform
qualit
test
detect
pev
even
though
panpev
assay
avail
specif
laboratori
diagnost
need
distinguish
ev
pev
ill
due
hsv
may
exhibit
similar
clinic
syndrom
earli
cours
ill
requir
empir
antivir
treatment
undergo
diagnost
evalu
larg
studi
infant
within
first
month
life
enrol
occur
peak
enteroviru
season
span
multipl
season
need
order
better
understand
ill
sever
manag
hospit
children
associ
individu
ev
pev
type
furthermor
increas
surveil
test
ev
pev
need
understand
sever
ill
infant
clinician
consid
ev
pev
infect
infant
present
acut
febril
ill
fund
studi
provid
cdc
nation
center
immun
respiratori
diseas
cooper
agreement
colorado
california
emerg
infect
program
site
